Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clinically Significant Portal Hypertension(CSPH)”

7 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 7 results

Not applicableStudy completedNCT05402644
What this trial is testing

Hepatectomy for Early-stage HCC Patients With CSPH

Who this might be right for
HCCPortal Hypertension
Tongji Hospital 320
Testing effectiveness (Phase 2)Ended earlyNCT06082843
What this trial is testing

Test Whether Avenciguat Helps People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver) Who Had Bleeding in the Esophagus or Fluid Accumulation in the Belly

Who this might be right for
Hypertension, PortalLiver Cirrhosis
Boehringer Ingelheim 22
Not applicableNot Yet RecruitingNCT07405749
What this trial is testing

Cirrhotic and Non-cirrhotic Patients With Clinically Significant Portal Hypertension

Who this might be right for
Cirrhosis, LiverPortal HypertensionClinically Significant Portal Hypertension(CSPH)+1 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 2,500
Testing effectiveness (Phase 2)Ended earlyNCT05282121
What this trial is testing

Test Whether BI 685509 Alone or in Combination With Empagliflozin Helps People With Liver Cirrhosis Caused by Viral Hepatitis or Non-alcoholic Steatohepatitis (NASH) Who Have High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)

Who this might be right for
Liver DiseasesHypertension, Portal
Boehringer Ingelheim 90
Testing effectiveness (Phase 2)Ended earlyNCT05161481
What this trial is testing

Test Whether Two Different Doses of Avenciguat Help People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)

Who this might be right for
Hypertension, Portal
Boehringer Ingelheim 80
Post-approval studies (Phase 4)Looking for participantsNCT07058155
What this trial is testing

Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease

Who this might be right for
Liver CirrhosesPortal Hypertension Related to CirrhosisSevere Obesity+1 more
The Cleveland Clinic 70
Not applicableUnknownNCT01860222
What this trial is testing

Surgical Resection Versus Percutaneous Local Ablative Therapy for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma With CSPH
Eastern Hepatobiliary Surgery Hospital 160